Skip to main content
SpringerLink
Log in

Wirksamkeit von Cetuximab und Irinotecan beim metastasierten kolorektalen Karzinom — EGF-Rezeptor-negativ

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Chung KY, Shia J, Kemeny NE et al. (2005) Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol 23:1803–1810

    Article  CAS  PubMed  Google Scholar 

  2. Cunningham D, Humblet Y, Siena S et al. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351:337–345

    CAS  PubMed  Google Scholar 

  3. Lenz HJ, Mayer RJ, Gold PJ et al. (2004) Activity of cetuximab in patients with colorectal cancer refractory to both irinotecan and oxaliplatin. Proc Am Soc Clin Oncol 22:247S

    Google Scholar 

  4. Lynch TJ, Bell DW, Sordella R et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129–2139

    Article  CAS  PubMed  Google Scholar 

  5. Meropol NJ (2005) Epidermal growth factor receptor inhibitors in colorectal cancer: it’s time to get back on target. J Clin Oncol 23:1791–1793

    Article  CAS  PubMed  Google Scholar 

  6. Paez JG, Janne PA, Lee JC et al. (2004) EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304:1497–1500

    Article  CAS  PubMed  Google Scholar 

  7. Saltz LB, Meropol NJ, Loehrer PJ Sr, Needle MN, Kopit J, Mayer RJ (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 22:1201–1208

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin m. S. Hämatologie, Onkologie und Tumorimmunologie, Robert-Rössle-Klinik der Charité, HELIOS-Klinikum Berlin-Buch

    A. Kretzschmar

  2. Klinik für Innere Medizin m. S. Hämatologie, Onkologie und Tumorimmunologie, Robert-Rössle-Klinik der Charité, HELIOS-Klinikum Berlin-Buch, 13122, Berlin

    A. Kretzschmar

Authors
  1. A. Kretzschmar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Kretzschmar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kretzschmar, A. Wirksamkeit von Cetuximab und Irinotecan beim metastasierten kolorektalen Karzinom — EGF-Rezeptor-negativ. Onkologe 11, 783–784 (2005). https://doi.org/10.1007/s00761-005-0902-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-005-0902-9

Search

Navigation